TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 75 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,237,403 | +121.2% | 125,909 | +124.9% | 0.08% | +110.8% |
| Q2 2023 | $1,011,414 | +93.5% | 55,972 | +34.6% | 0.04% | +76.2% |
| Q1 2023 | $522,573 | -14.3% | 41,573 | 0.0% | 0.02% | -30.0% |
| Q4 2022 | $609,460 | -14.4% | 41,573 | 0.0% | 0.03% | -11.8% |
| Q3 2022 | $712,000 | -4.0% | 41,573 | -18.2% | 0.03% | -5.6% |
| Q2 2022 | $742,000 | +319.2% | 50,826 | +382.0% | 0.04% | +350.0% |
| Q1 2022 | $177,000 | -63.0% | 10,544 | -52.5% | 0.01% | -66.7% |
| Q3 2021 | $478,000 | -51.1% | 22,198 | -34.2% | 0.02% | -36.8% |
| Q2 2021 | $978,000 | – | 33,751 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |